The European Commission has signed a contract with the pharmaceutical company Gilead to secure treatment doses of Veklury, the brand name for Remdesivir. Veklury was the first medicine authorised at EU level for treatment of COVID-19. As from early August onwards, and in order to meet immediate needs, batches of Veklury will be made available to Member States and the UK, with the coordination and support of the Commission.
The Commission has presented 3 immediate initiatives to implement the Security Union Strategy: an EU strategy for a more effective fight against child abuse; a new EU Agenda and Action Plan on Drugs and an EU Action Plan on firearms trafficking. These threats all require resolute EU-level action as they are cross-border in nature and active both online and offline. They have also been worsened by the coronavirus pandemic, particularly child sexual abuse, demonstrably exacerbated by physical isolation and increased online activity. Fighting drug and firearms trafficking is key to action against organised crime, a top internal security priority across Europe.
On Wednesday 2 September Michel Barnier, Head of the EU Task Force for Relations with the United Kingdom, will address a webinar on the state of play in the negotiations on the future relationship between the EU and the UK, the obstacles on the road to an agreement, and the key issues that will shape the relationship in the years to come.
This online event is co-organised by the Institute of International and European Affairs (IIEA) and the European Commission Representation in Ireland. It is open to the public and free to attend.